TOKYO -- The Japanese government will spend about $1.5 billion to support the homegrown development of vaccines, Nikkei has learned, as it grapples with uncertainties from relying on imported coronavirus inoculations.
As part of the program, Japan will partner with other Asian nations to create a cross-border network for clinical research and clinical trials to promote speedy development. The government will also assume part of the cost burden for domestic pharmaceutical companies and research institutions that develop vaccines.
